The DOI matches its Crossref record; 15 of the 15 references it cites were found in a registry or an index.
Herd Immunity: Understanding COVID-19
Open accessAbstract
The emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and its associated disease, COVID-19, has demonstrated the devastating impact of a novel, infectious pathogen on a susceptible population. Here, we explain the basic concepts of herd immunity and discuss its implications in the context of COVID-19.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
Huang, C., Wang, Y., Li, X., Ren, L., Zhao, J., Hu, Y., Zhang, L., Fan, G., Xu, J., Gu, X., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30183-5 · Cited by 48,884
Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia
Li, Q., Guan, X., Wu, P., Wang, X., Zhou, L., Tong, Y., Ren, R., Leung, K. S. M., Lau, E. H. Y., Wong, J. Y., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2001316 · Cited by 16,575
Estimates of the severity of coronavirus disease 2019: a model-based analysis
Verity, R., Okell, L. C., Dorigatti, I., Winskill, P., Whittaker, C., Imai, N., Cuomo-Dannenburg, G., Thompson, H., Walker, P. G. T., Fu, H., et al. (2020) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(20)30243-7 · Cited by 3,660
Projecting the transmission dynamics of SARS-CoV-2 through the postpandemic period
Kissler, S. M., Tedijanto, C., Goldstein, E., Grad, Y. H., & Lipsitch, M. (2020) · Science · doi:10.1126/science.abb5793 · Cited by 2,611
Superspreading and the effect of individual variation on disease emergence
Lloyd-Smith, J. O., Schreiber, S. J., Kopp, P. E., & Getz, W. M. (2005) · Nature · doi:10.1038/nature04153 · Cited by 2,514
High Contagiousness and Rapid Spread of Severe Acute Respiratory Syndrome Coronavirus 2
Sanche, S., Lin, Y. T., Xu, C., Romero-Severson, E., Hengartner, N., & Ke, R. (2020) · Emerging Infectious Diseases · doi:10.3201/eid2607.200282 · Cited by 1,619
Estimating clinical severity of COVID-19 from the transmission dynamics in Wuhan, China
Wu, J. T., Leung, K., Bushman, M., Kishore, N., Niehus, R., de Salazar, P. M., Cowling, B. J., Lipsitch, M., & Leung, G. M. (2020) · Nature Medicine · doi:10.1038/s41591-020-0822-7 · Cited by 1,311
Complexity of the Basic Reproduction Number (R0)
Delamater, P. L., Street, E. J., Leslie, T. F., Yang, Y. T., & Jacobsen, K. H. (2019) · Emerging Infectious Diseases · doi:10.3201/eid2501.171901 · Cited by 860
Vaccination and herd immunity to infectious diseases
Anderson, R. M., & May, R. M. (1985) · Nature · doi:10.1038/318323a0 · Cited by 781
Wu, F., Wang, A., Liu, M., Wang, Q., Chen, J., Xia, S., Ling, Y., Zhang, Y., Xun, J., Lu, L., et al. (2020) · doi:10.1101/2020.03.30.20047365 · Cited by 754
Cited by
Wang, D., Hu, B., Hu, C., Zhu, F., Liu, X., Zhang, J., Wang, B., Xiang, H., Cheng, Z., Xiong, Y., et al. (2020) · JAMA · doi:10.1001/jama.2020.1585 · Cited by 20,148
Ciotti, M., Ciccozzi, M., Terrinoni, A., Jiang, W.-C., Wang, C.-B., & Bernardini, S. (2020) · Critical Reviews in Clinical Laboratory Sciences · doi:10.1080/10408363.2020.1783198 · Cited by 1,514
Paul, E., Steptoe, A., & Fancourt, D. (2021) · The Lancet Regional Health - Europe · doi:10.1016/j.lanepe.2020.100012 · Cited by 1,013
Transmissibility and transmission of respiratory viruses
Leung, N. H. L. (2021) · Nature Reviews Microbiology · doi:10.1038/s41579-021-00535-6 · Cited by 890
Factors Associated with COVID-19 Vaccine Hesitancy
Soares, P., Rocha, J. V., Moniz, M., Gama, A., Laires, P. A., Pedro, A. R., Dias, S., Leite, A., & Nunes, C. (2021) · Vaccines · doi:10.3390/vaccines9030300 · Cited by 708
Predictors of COVID-19 vaccine hesitancy in the UK household longitudinal study
Robertson, E., Reeve, K. S., Niedzwiedz, C. L., Moore, J., Blake, M., Green, M., Katikireddi, S. V., & Benzeval, M. J. (2021) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2021.03.008 · Cited by 690
A Review of the Progress and Challenges of Developing a Vaccine for COVID-19
Sharma, O., Sultan, A. A., Ding, H., & Triggle, C. R. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.585354 · Cited by 546
Impacts of COVID-19 pandemic on urban park visitation: a global analysis
Geng, D. (., Innes, J., Wu, W., & Wang, G. (2021) · Journal of Forestry Research · doi:10.1007/s11676-020-01249-w · Cited by 531
Immunological characteristics govern the transition of COVID-19 to endemicity
Lavine, J. S., Bjornstad, O. N., & Antia, R. (2021) · Science · doi:10.1126/science.abe6522 · Cited by 416
Cascini, F., Pantovic, A., Al-Ajlouni, Y., Failla, G., & Ricciardi, W. (2021) · EClinicalMedicine · doi:10.1016/j.eclinm.2021.101113 · Cited by 396
Next-generation vaccine platforms for COVID-19
van Riel, D., & de Wit, E. (2020) · Nature Materials · doi:10.1038/s41563-020-0746-0 · Cited by 374
Coronavirus herd immunity optimizer (CHIO)
Al-Betar, M. A., Alyasseri, Z. A. A., Awadallah, M. A., & Abu Doush, I. (2021) · Neural Computing and Applications · doi:10.1007/s00521-020-05296-6 · Cited by 372
A Time-Dependent SIR Model for COVID-19 With Undetectable Infected Persons
Chen, Y.-C., Lu, P.-E., Chang, C.-S., & Liu, T.-H. (2020) · IEEE Transactions on Network Science and Engineering · doi:10.1109/tnse.2020.3024723 · Cited by 370
Yaseen, M. O., Saif, A., Khan, T. M., Yaseen, M., Saif, A., Bukhsh, A., Shahid, M. N., Alsenani, F., Tahir, H., Ming, L. C., et al. (2022) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2022.2031455 · Cited by 347
Edwards, B., Biddle, N., Gray, M., & Sollis, K. (2021) · PLOS ONE · doi:10.1371/journal.pone.0248892 · Cited by 339
Trust in science, social consensus and vaccine confidence
Sturgis, P., Brunton-Smith, I., & Jackson, J. (2021) · Nature Human Behaviour · doi:10.1038/s41562-021-01115-7 · Cited by 323
Allam, Z., & Jones, D. S. (2021) · Land Use Policy · doi:10.1016/j.landusepol.2020.105201 · Cited by 299
SARS-CoV-2 Variants, Vaccines, and Host Immunity
Mistry, P., Barmania, F., Mellet, J., Peta, K., Strydom, A., Viljoen, I. M., James, W., Gordon, S., & Pepper, M. S. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2021.809244 · Cited by 299
Willingness to vaccinate against COVID-19 in Australia
Dodd, R. H., Cvejic, E., Bonner, C., Pickles, K., McCaffery, K. J., Ayre, J., Batcup, C., Copp, T., Cornell, S., Dakin, T., et al. (2021) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(20)30559-4 · Cited by 280
COVID‐19 vaccination intention in the first year of the pandemic: A systematic review
Al‐Amer, R., Maneze, D., Everett, B., Montayre, J., Villarosa, A. R., Dwekat, E., & Salamonson, Y. (2022) · Journal of Clinical Nursing · doi:10.1111/jocn.15951 · Cited by 276
Alqudeimat, Y., Alenezi, D., AlHajri, B., Alfouzan, H., Almokhaizeem, Z., Altamimi, S., Almansouri, W., Alzalzalah, S., & Ziyab, A. H. (2021) · Medical Principles and Practice · doi:10.1159/000514636 · Cited by 266
Prospects for durable immune control of SARS-CoV-2 and prevention of reinfection
Cromer, D., Juno, J. A., Khoury, D., Reynaldi, A., Wheatley, A. K., Kent, S. J., & Davenport, M. P. (2021) · Nature Reviews Immunology · doi:10.1038/s41577-021-00550-x · Cited by 265
A systematic literature review to clarify the concept of vaccine hesitancy
Bussink-Voorend, D., Hautvast, J. L. A., Vandeberg, L., Visser, O., & Hulscher, M. E. J. L. (2022) · Nature Human Behaviour · doi:10.1038/s41562-022-01431-6 · Cited by 260
COVID-19 vaccine-readiness for anti-CD20-depleting therapy in autoimmune diseases
Baker, D., Roberts, C. A. K., Pryce, G., Kang, A. S., Marta, M., Reyes, S., Schmierer, K., Giovannoni, G., & Amor, S. (2020) · Clinical and Experimental Immunology · doi:10.1111/cei.13495 · Cited by 192
de Alwis, R., Gan, E. S., Chen, S., Leong, Y. S., Tan, H. C., Zhang, S. L., Yau, C., Low, J. G. H., Kalimuddin, S., Matsuda, D., et al. (2021) · Molecular Therapy · doi:10.1016/j.ymthe.2021.04.001 · Cited by 191
COVID-19 Vaccine Acceptance and Beliefs among Black and Hispanic Americans
Kricorian, K., & Turner, K. (2021) · PLOS ONE · doi:10.1371/journal.pone.0256122 · Cited by 161
Benham, J. L., Atabati, O., Oxoby, R. J., Mourali, M., Shaffer, B., Sheikh, H., Boucher, J.-C., Constantinescu, C., Parsons Leigh, J., Ivers, N. M., et al. (2021) · JMIR Public Health and Surveillance · doi:10.2196/30424 · Cited by 67
Nkuba, A. N., Makiala, S. M., Guichet, E., Tshiminyi, P. M., Bazitama, Y. M., Yambayamba, M. K., Kazenza, B. M., Kabeya, T. M., Matungulu, E. B., Baketana, L. K., et al. (2022) · Clinical Infectious Diseases · doi:10.1093/cid/ciab515 · Cited by 51
NIH funding for vaccine readiness before the COVID-19 pandemic
Kiszewski, A. E., Cleary, E. G., Jackson, M. J., & Ledley, F. D. (2021) · Vaccine · doi:10.1016/j.vaccine.2021.03.022 · Cited by 38
Infection fatality ratio and case fatality ratio of COVID-19
Luo, G., Zhang, X., Zheng, H., & He, D. (2021) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2021.10.004 · Cited by 36
Pratama, N. R., Wafa, I. A., Budi, D. S., Sutanto, H., Asmarawati, T. P., Barlian Effendi, G., & Wungu, C. D. K. (2022) · Vaccines · doi:10.3390/vaccines10122180 · Cited by 30
“Earlier in the COVID-19 pandemic, studies predicted a 60–90% herd immunity threshold to limit the disease spreading, which could be achieved through several measures, including a mass vaccination campaign [7,8].”
Lin, Y.-J., Chou, W.-J., Chang, Y.-P., & Yen, C.-F. (2021) · Vaccines · doi:10.3390/vaccines9080822 · Cited by 8
“Researchers estimated that the herd immunity threshold for COVID-19 requires that approximately 67% of a population be vaccinated [11].”
Parthasarathi, A., Puvvada, R. K., Basappa, S., Krishna, M. T., & P A, M. (2022) · Wellcome Open Research · doi:10.12688/wellcomeopenres.17517.1 · Cited by 7
Metadata
- Authors
- Randolph, H. E., & Barreiro, L. B.
- Venue
- Immunity
- Publisher
- Elsevier BV
- Published
- 2020-05
- Volume
- 52
- Issue
- 5
- Pages
- 737-741
- ISSN
- 1074-7613 (ISSN-L)
- OpenAlex
- W3020062806
- Cited by
- 1,138
- References
- 15
- FWCI
- 30.33
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.